BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28029307)

  • 21. Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations.
    Rizzo FM; Palmirotta R; Marzullo A; Resta N; Cives M; Tucci M; Silvestris F
    BMC Cancer; 2016 Feb; 16():87. PubMed ID: 26867653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic significance of clinicopathologic parameters in gastrointestinal stromal tumor: a study of 156 cases].
    Liang YM; Li XH; Lü YY; Lü YL; Zhong M; Pu XL; Li WM
    Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):233-8. PubMed ID: 17706113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
    Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
    Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors.
    Novitsky YW; Kercher KW; Sing RF; Heniford BT
    Ann Surg; 2006 Jun; 243(6):738-45; discussion 745-7. PubMed ID: 16772777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological and molecular aspects of foregut gastrointestinal stromal tumours.
    Chen J; Gundara JS; Haddad R; Schiavone V; Meldrum C; Samra JS; Gill AJ; Hugh TJ
    ANZ J Surg; 2014; 84(1-2):52-8. PubMed ID: 23171083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrointestinal stromal tumors (GIST) related emergencies.
    Sorour MA; Kassem MI; Ghazal Ael-H; El-Riwini MT; Abu Nasr A
    Int J Surg; 2014; 12(4):269-80. PubMed ID: 24530605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy.
    Huss S; Elges S; Trautmann M; Sperveslage J; Hartmann W; Wardelmann E
    Expert Rev Anticancer Ther; 2015 Jun; 15(6):623-8. PubMed ID: 25831232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational profile of KIT and PDGFRA genes in gastrointestinal stromal tumors in Peruvian samples.
    Buleje J; Acosta Ó; Guevara-Fujita M; Enriquez Y; Taxa L; Machicado E; Lizaraso-Caparó F; Fujita R
    Rev Esp Enferm Dig; 2015 Feb; 107(2):72-8. PubMed ID: 25659388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
    Hayashi Y; Bardsley MR; Toyomasu Y; Milosavljevic S; Gajdos GB; Choi KM; Reid-Lombardo KM; Kendrick ML; Bingener-Casey J; Tang CM; Sicklick JK; Gibbons SJ; Farrugia G; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Ramachandran A; Ordog T
    Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction.
    Nannini M; Astolfi A; Paterini P; Urbini M; Santini D; Catena F; Indio V; Casadio R; Pinna AD; Biasco G; Pantaleo MA
    Future Oncol; 2013 Jan; 9(1):121-6. PubMed ID: 23252569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
    Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y
    Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectrum and prognostication of KIT and PDGFRA mutation in gastrointestinal stromal tumors.
    Tzen CY; Wang MN; Mau BL
    Eur J Surg Oncol; 2008 May; 34(5):563-8. PubMed ID: 17532173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors.
    Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P
    Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laparoscopic versus open resection of gastrointestinal stromal tumors: survival outcomes from the NCDB.
    Inaba CS; Dosch A; Koh CY; Sujatha-Bhaskar S; Pejcinovska M; Smith BR; Nguyen NT
    Surg Endosc; 2019 Mar; 33(3):923-932. PubMed ID: 30171396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group.
    Patrikidou A; Domont J; Chabaud S; Ray-Coquard I; Coindre JM; Bui-Nguyen B; Adenis A; Rios M; Bertucci F; Duffaud F; Chevreau C; Cupissol D; Pérol D; Emile JF; Blay JY; Le Cesne A;
    Eur J Cancer; 2016 Jan; 52():173-80. PubMed ID: 26687836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of recurrence after resection of small gastric gastrointestinal stromal tumors of 5 cm or less.
    Kim MY; Park YS; Choi KD; Lee JH; Choi KS; Kim DH; Song HJ; Lee GH; Jung HY; Kim JH; Yun SC; Kim KC; Yook JH; Oh ST; Kim BS; Ryu MH; Kang YK
    J Clin Gastroenterol; 2012 Feb; 46(2):130-7. PubMed ID: 21617541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imatinib efficacy by tumor genotype in Korean patients with advanced gastrointestinal stromal tumors (GIST): The Korean GIST Study Group (KGSG) study.
    Kang HJ; Ryu MH; Kim KM; Park YS; Choi J; Ryoo BY; Kim WH; Im SA; Bang YJ; Park SH; Lee JH; Chung IJ; Bae HI; Kim JG; Lee KH; Song HS; Kwon HC; Baek JH; Shin DB; Lee KE; Kang YK
    Acta Oncol; 2012 Apr; 51(4):528-36. PubMed ID: 22150077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.
    Rossi S; Sbaraglia M; Dell'Orto MC; Gasparotto D; Cacciatore M; Boscato E; Carraro V; Toffolatti L; Gallina G; Niero M; Pilozzi E; Mandolesi A; Sessa F; Sonzogni A; Mancini C; Mazzoleni G; Romeo S; Maestro R; Dei Tos AP
    Oncotarget; 2016 May; 7(21):30109-18. PubMed ID: 27097112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
    He HY; Fang WG; Zhong HH; Li Y; Zheng J; Du J; Heng WJ; Wu BQ
    Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.